Inhibition and Stimulation of Long-Chain Fatty Acid Oxidation by Chloroacetaldehyde and Methylene Blue in Rats
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
The effects of chloroacetaldehyde (CAA) and methylene blue, both alone and together, on mitochondrial metabolism, hepatic glutathione content, and bile flow were investigated in rats. Oxidation of [1-14C]palmitic acid, [1-14C]octanoic acid, and [1,4-14C]succinic acid allowed for the differentiation between carnitine-dependent long-chain fatty acid metabolism, medium chain fatty acid oxidation, and citric acid cycle activity, respectively. CAA, a metabolite of the anticancer drug ifosfamide, which may be responsible for ifosfamide-induced encephalopathy, inhibited palmitic acid metabolism but not octanoic or succinic acid oxidation, depleted hepatic glutathione, and stimulated bile flow. Methylene blue, which is clinically used to either prevent or reverse ifosfamide-associated encephalopathy, markedly stimulated palmitic acid oxidation either in the presence or absence of CAA, but did not affect the oxidation of octanoic and succinic acid or hepatic glutathione. Taken together, this study demonstrates that CAA inhibits palmitic acid metabolism. Methylene blue stimulates long-chain fatty acid oxidation, most likely by facilitating the translocation of fatty acids into mitochondria, and compensates for the CAA effect in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is very interesting that the response of C. albicans to respiratory inhibition is similar to what has been seen in mammalian cells [53].”
From Mitochondrial Activity and Cyr1 Are Key Regulators of Ras1 Activation of C. albicans Virulence Pathways (2015) · cites this paper as [53]
Citations
Cites
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666 · cited 3×
“To localize potential sites of action we examined the influence of CAA and methylene blue on the oxidation of: 1) succinic acid, a substrate for the citric acid cycle; 2) octanoic acid, a medium chain fatty acid and substrate for b-oxidation that may pass through the mitochondrial inner membrane without prior activati…”
High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives
Fariss, M. W., & Reed, D. J. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)43018-8 · Cited by 503
Newton, G. L., Dorian, R., & Fahey, R. C. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90498-x · Cited by 451 · cited 1×
“(Newton et al., 1981).”
The effect of some carbonyl compounds on rat liver glutathione levels
Boyland, E., & Chasseaud, L. F. (1970) · Biochemical Pharmacology · doi:10.1016/0006-2952(70)90075-4 · Cited by 264
DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITY
Goren, M. P., Wright, R. K., Pratt, C. B., & Pell, F. E. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92227-0 · Cited by 211 · cited 1×
“, 1995) and has been suggested as a causative factor contributing to the neurotoxicity associated with ifosfamide chemotherapy (Goren et al., 1986).”
Dechant, K. L., Brogden, R. N., Pilkington, T., & Faulds, D. (1991) · Drugs · doi:10.2165/00003495-199142030-00006 · Cited by 182 · cited 1×
“Ifosfamide, an oxazaphosphorine-alkylating agent effective against a broad spectrum of neoplasms, produces chloroacetaldehyde (CAA) in the course of its metabolism (Sechant et al., 1991).”
BackgroundProphylaxis and reversal of ifosfamide encephalopathy with methylene-blue
Küpfer, A., Aeschlimann, C., Wermuth, B., & Cerny, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91839-2 · Cited by 178 · cited 1×
“Clinically, the redox dye methylene blue is used to prevent and reverse ifosfamide-induced encephalopathy (Küpfer et al., 1994; Ferrero et al., 1995), although the mechanism of action is poorly understood.”
DANIEL, F. (1992) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(92)90147-a · Cited by 166
Nachmansohn, D. A. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195310000-00011 · Cited by 129
Robishaw, J. D., & Neely, J. R. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.1.e1 · Cited by 122 · cited 9×
“In the intermembranous space, the acyl-CoA is converted to acylcarnitine, which is subsequently transported across the mitochondrial inner membrane by carnitine translocase (Bremer, 1983).”
Influential
Research works printed but not linked: 1
- Ferrero, 1995, Traitement d’une encéphalopathie à l’ifosfamide par le bleu de méthylène., Bull Cancer (Paris), 82, 598
Cited by
Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways
Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., & Ames, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9610com · Cited by 272
Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue
Rojas, J. C., Bruchey, A. K., & Gonzalez-Lima, F. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.007 · Cited by 172
“Additional evidence supports that MB also influences biochemical mechanisms dependent on mitochondrial respiration such as lipid b-oxidation (Visarius et al., 1999), glycolysis, ATP synthesis, extracellular matrix production (Lee and Urban, 2002) and Na+/K+ ATPase activity (Furian et al., 2007).”
Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase
Atamna, H., & Kumar, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100414 · Cited by 155
“MB also protects from ischemic-reperfusion injury [144], radiation [145], and enhances β-oxidation of long chain fatty acids [146].”
Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites
Kerbusch, T., de Kraker, J., Keizer, H. J., van Putten, J. W. G., Groen, H. J. M., Jansen, R. L. H., Schellens, J. H. M., & Beijnen, J. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140010-00004 · Cited by 145
“Methylene blue was also able to compensate for the effect of chloroacetaldehyde on long-chain fatty acid oxidation, thus preventing encephalopathy and fatigue.[174]”
BackgroundCancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system
Peluso, G., Nicolai, R., Reda, E., Benatti, P., Barbarisi, A., & Calvani, M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<339::aid-jcp4>3.0.co;2-b · Cited by 140
Metadata
- Authors
- Visarius, T. M., Stucki, J. W., & Lauterburg, B. H.
- Affiliations
- University of Bern (CH)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 289
- Issue
- 2
- Pages
- 820-824
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2121045940
- Cited by
- 58
- References
- 26
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 4
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- chloroacetaldehyde, methylene blue, long-chain fatty acid oxidation, palmitic acid oxidation, ifosfamide, hepatic glutathione, bile flow, TCA cycle, liver mitochondria
- MeSH terms
- Acetaldehyde, Animals, Bile, Caprylates, Coloring Agents, Fatty Acids, Glutathione, Male, Methylene Blue, Mitochondria, Oxidation-Reduction, Rats, Wistar, Palmitic Acid, Succinic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition and Stimulation of Long-Chain Fatty Acid Oxidation by Chloroacetaldehyde and Methylene Blue in Rats. https://app.cochat.ai/papers/10.1016/s0022-3565(24)38206-0
- The paper
- Visarius, T. M., Stucki, J. W., & Lauterburg, B. H. (1999). Inhibition and Stimulation of Long-Chain Fatty Acid Oxidation by Chloroacetaldehyde and Methylene Blue in Rats. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)38206-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.